High-resolution 1 H NMR spectroscopy of amniotic fluids from spina bifida fetuses and controls

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 112, Issue 1, 2004, Pages 16-23

  Groenen, Pascal M W ^a   Engelke, Udo F ^a   Wevers, Ron A ^a   Hendriks, Jan C M ^a   Eskes, Tom K A B ^a   Merkus, Hans M W M ^a   Steegers Theunissen, Régine P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1 H NMR spectroscopy; Amniotic fluid; Carbohydrates; Neural tube defects

Indexed keywords

AMINO ACID; CARBOHYDRATE; CARBOXYLIC ACID; CREATINE; CREATININE; GLUTAMINE; LACTIC ACID; SUCCINIC ACID; BIOLOGICAL MARKER;

AMENORRHEA; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; LINEAR REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SPINA BIFIDA; ADULT; AMNIOCENTESIS; CASE CONTROL STUDY; CHEMISTRY; GESTATIONAL AGE; METHODOLOGY; MULTIVARIATE ANALYSIS; NEURAL TUBE DEFECT; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; AMINO ACIDS; AMNIOCENTESIS; AMNIOTIC FLUID; BIOLOGICAL MARKERS; CARBOHYDRATES; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPINAL DYSRAPHISM;

EID: 0346995449     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00279-3     Document Type: Article

References (17)

1. Moolenaar S.H., Poggi-Bach J., Engelke U.F., Corstiaensen J.M., Heerschap A., de Jong J.G., Binzak B.A., Vockley J., Wevers R.A. Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin. Chem. 45(4):1999;459-464.
2. Bell J.D., Brown J.C., Sadler P.J. NMR studies of body fluids. NMR Biomed. 2(5-6):1989;246-256.
3. Bock J.L. Metabolic profiling of amniotic fluid by proton nuclear magnetic resonance spectroscopy: correlation with fetal maturation and other clinical variables. Clin. Chem. 40(1):1994;56-61.
4. Reece E.A., Homko C.J., Wu Y.K., Wiznitzer A. The role of free radicals and membrane lipids in diabetes-induced congenital malformations. J. Soc. Gynecol. Invest. 5(4):1998;178-187.
5. Greene N.D., Copp A.J. Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med. 3(1):1997;60-66.
6. Steegers-Theunissen R.P., Boers G.H., Blom H.J., Nijhuis J.G., Thomas C.M., Borm G.F., Eskes T.K.A.B. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am. J. Obstet. Gynecol. 172(5):1995;1436-1441.
7. Weston J.A. The regulation of normal and abnormal neural crest cell development. Adv. Neurol. 29:1981;77-95.
8. 1 H NMR of cerebrospinal fluid Clin. Chem. 41(5):1995;744-751.
9. 1 H NMR analysis of amniotic fluid J. Pharm. Biomed. Anal. 11(8):1993;629-632.
10. Nelson T.R., Gillies R.J., Powell D.A., Schrader M.C., Manchester D.K., Pretorius D.H. High resolution proton NMR spectroscopy of human amniotic fluid. Prenat. Diagn. 7(5):1987;363-372.
11. Boss E.A., Moolenaar S.H., Massuger L.F., Boonstra H., Engelke U.F., de Jong J.G., Wevers R.A. High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR Biomed. 13(5):2000;297-305.
12. 1 H NMR spectroscopy of blood plasma for metabolic studies Clin. Chem. 40(7 Pt 1):1994;1245-1250.
13. Weiss P.A., Hofmann H., Winter R., Purstner P., Lichtenegger W. Amniotic fluid glucose values in normal and abnormal pregnancies. Obstet. Gynecol. 65(3):1985;333-339.
14. Bell J.D., Brown J.C., Sadler P.J., Macleod A.F., Sonksen P.H., Hughes R.D., Williams R. High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. Clin. Sci. (Colch). 72(5):1987;563-570.
15. Young V.R., Ajami A.M. Glutamine: the emperor or his clothes? J. Nutr. 131(Suppl 9):2001;2449S-2459S.
16. Duckworth T., Bond P.A., McKibbin B., Mitchell E.C. Urinary excretion of tyrosine metabolites in spina bifida. Clin. Chim. Acta. 43(2):1973;249-255.
17. McKibbin B., O'Gorman L., Duckworth T. Catecholamine metabolite excretion in spina bifida. J. Clin. Pathol. 22(6):1969;687-689.